Pulse Infoframe and QualityMetric Partner to Develop Novel Rare Disease Solution Learn More.
Pulse Infoframe and QualityMetric Partner to Develop Novel Rare Disease Solution Learn More.
Our research consultants have decades of experience in PRO measurement across diverse therapeutic conditions. We work closely with pharmaceutical, medical device and healthcare organizations on data measurement that aligns with regulatory recommendations in the U.S. and other geographies. Our scientifically led approach includes the analysis of any PRO measure, the burden of illness, and treatment effectiveness.
Scientific ConsultingQualityMetric’s eCOA platform is a robust data collection, scoring and reporting portal. It can be custom tailored with the features and functionality needed to securely and accurately capture data from patients, clinicians or caregivers. Our scientists combine health outcomes expertise with our technology platform to identify the right measurement concepts for collecting the most insightful and patient-centric evidence.
COA Solutions & Licensing ServicesQualityMetric offers unique solutions for translation and cross-cultural adaptation. Guided by industry standards, we translate and validate all types of materials used in health care and the life sciences. We collaborate with hundreds of experienced local and international linguistic partners, overseeing every stage of the development process. Our goal is absolute conceptual equivalence, cultural appropriateness and content validity.
Translation & Linguistic ValidationQualityMetric’s Short Form family of generic health surveys – in particular the SF-36v2® and SF-12v2® – includes the most widely used and cited PROs in the world. Designed for use across the product lifecycle, they are an efficient, scientifically valid way of evaluating safety and efficacy, real world evidence through product performance, and post authorization safety surveillance; and they support post-launch direct-to-consumer (DTC) marketing and disease management.
QualityMetric collaborates with the world’s largest life science and healthcare organizations to measure and better understand health outcomes. We are also committed to supporting global academic institutions by making our clinical outcome assessment (COA) solutions royalty-free for students and university researchers.
From health surveys to expert analysis and methodologies, QualityMetric delivers all-inclusive outcome measurement solutions for capturing, benchmarking, and interpreting actionable patient-reported health information. For licensing requests, scientific consulting services, or linguistic translation and validation, please complete the following contact form.
Select the organization that best describes your company:
QualityMetric is reviewing your application and will get back to you shortly with approval to move forward with a license to administer, collect, score, and interpret the data for your project/study.
Next steps:
If you have started administering the survey, please email a copy of the survey being administered to license@qualitymetric.com. We will QA the form for any changes that may affect the scoring and interpretation of the data collected. (Fees may apply).
If you are applying for a student license, please email a copy of your student ID to license@qualitymetric.com.
In the United States, more than 30 million people live with one of nearly 7,000 known rare diseases. Rare diseases affect extremely small segments of the population—by definition, fewer than 200,000 individuals—and they leave researchers with even smaller patient populations to use in discovering new therapeutic options. As children make up around half of those living with rare diseases, accurate diagnoses often take years to achieve, and some very rare diseases are left undiagnosed.
QualityMetric and Pulse Infoframe announced today their partnership and vision to create the first scientifically validated rare disease instruments across conditions. Once deployed, these instruments will benefit not only rare disease patients and families, but also researchers and drug developers working to help this vastly underserviced population as they advance rare disease care and treatments.
Read MoreMs. Host’s distinguished career spans 20+ years, with progressively larger leadership roles in healthcare across life sciences, provider, and payer markets.
Read MoreMr. Hart will join the team led by Chief Executive Officer Garth “Gus” Gardner, who has been in that role since soon after the VSCP-led recapitalization of the company in August of 2020.
Read MoreQualityMetric’s own Kimberly Raymond, Andrew Lovley, and Michelle White co-author a new study on the humanistic burden of hereditary transthyretin (hATTR) amyloidosis from the patient’s perspective.
Read MoreQualityMetric’s Vice President and Senior Scientist, Mark Kosinski, co-authors a study for determining whether the content of the Asthma Control Test (ACT) serves as a valid measure of asthma control.
Read MoreOur experts provide medical device clients with leading strategic measurement services, qualitative and quantitative research and patient journey studies, PRO outcomes analyses, rare disease research, and PRO regulatory support services.
Read More
Learn how to generate evidence for new therapies with COA measures.